RxDoctor Payments Data

Tera Santistevan, DPM

Podiatrist · Sapulpa, OKNPI 1588174841

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medwest Associates at 32.7% of the total. Reporting peaked in 2021 at $2,910 and has fallen 86.1% since, to $405 in 2025.

$5,441in general payments, 2019–2025

Across 64 payments — averaging $85.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medwest Associates$2K
  • Stryker$1K
  • Organogenesis Inc.$319
  • Restor3d, Inc.$276
  • Kerecis Limited$257
  • Treace Medical Concepts, Inc.$242
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$73814%
  • Food & beverage$2,93454%
  • Education$1,76933%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,441 in reported general payments places this provider in the 85th percentile of 54 podiatrist providers in Oklahoma.

See all podiatrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$100,948
Medicare patients
305
Services billed
1,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine31$264
Terbinafine Hcl14$238
Econazole Nitrate15$235
Meloxicam55$204
Methylprednisolone21$178

Paid to pharmacies, not to this prescriber.

Other podiatrist in Sapulpa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →